Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference Life Science Investing
Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update Life Science Investing
Novavax Reports First Quarter 2026 Financial Results and Operational Highlights Life Science Investing
Annexon to Present at the Bank of America Securities Health Care Conference 2026 Life Science Investing
BriaCell Receives FDA Clearance to Initiate Bria-BRES+ Clinical Study in Breast Cancer Biotech Investing
Anavex Life Sciences Board of Directors Appoints Former Senior Vice President of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer Life Science Investing
TScan Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update Life Science Investing
Eupraxia Pharmaceuticals' First Release of EoEHSS Sub Scores Data from its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis at Digestive Disease Week Life Science Investing
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board for Phase 3 Study in Metastatic Breast Cancer
